Literature DB >> 17628708

Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice.

Batbayar Tumurbaatar1, Yixiao Sun, Tehsheng Chan, Jiaren Sun.   

Abstract

Hepatocyte apoptosis is an important feature of liver injury in hepatitis C virus (HCV) infection. However, the mechanism of apoptosis and consequences on disease progression in vivo have not been investigated fully in part due to the lack of adequate small animal models. In this study, transgenic (tg) mice were produced that express conditionally HCV structural proteins (core, E1, E2 and p7) in the liver following Cre-mediated DNA recombination. Using a novel Cre-estrogen receptor fusion protein (Cre-ER) induction strategy, tamoxifen was injected intraperitoneally (i.p.), which induced Cre nuclear translocation, transgene recombination and HCV protein expression in the liver. Hepatic expression of HCV core and envelope proteins resulted in increased hepatocyte apoptosis, detected by the TUNEL assay, between 7 and 33 days after induction. These results were confirmed by the presence of increased levels of apoptosis-associated cytokeratin 18 (CK-18) in the sera of the same animals. The presence of cleaved caspase-3 and elevated levels of CHOP/GADD153 in the liver suggests an endoplasmic reticulum (ER) stress-associated apoptosis mechanism. This study suggests an in vivo correlation between HCV structural protein expression, ER stress and hepatocyte apoptosis, implicating a potentially important mechanism of HCV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628708      PMCID: PMC2104783          DOI: 10.1016/j.jviromet.2007.05.025

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  48 in total

1.  Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production.

Authors:  Masaaki Korenaga; Ting Wang; Yanchun Li; Lori A Showalter; Tehsheng Chan; Jiaren Sun; Steven A Weinman
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

Review 2.  An apoptosis biomarker goes to the HCV clinic.

Authors:  Ariel E Feldstein; Gregory J Gores
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

3.  Hepatitis C virus, ER stress, and oxidative stress.

Authors:  Keith D Tardif; Gulam Waris; Aleem Siddiqui
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 4.  Dysregulation of apoptosis as a mechanism of liver disease: an overview.

Authors:  T Patel; L R Roberts; B A Jones; G J Gores
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

5.  Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.

Authors:  Jiaren Sun; Batbayar Tumurbaatar; Junhui Jia; Hong Diao; Francis Bodola; Stanley M Lemon; Wendell Tang; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino; Teh-Sheng Chan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein.

Authors:  Victor V Keasler; Herve Lerat; Charles R Madden; Milton J Finegold; Michael J McGarvey; Essam M A Mohammed; Stuart J Forbes; Stanley M Lemon; Darryl L Hadsell; Shala J Grona; F Blaine Hollinger; Betty L Slagle
Journal:  Virology       Date:  2006-01-20       Impact factor: 3.616

7.  Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients.

Authors:  C M Rodrigues; D Brites; F Serejo; A Costa; F Ramalho; M C De Moura
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

8.  The immunologic basis for hepatitis C infection.

Authors:  Jiaren Sun; Kui Li; Mohamed Tarek Shata; Teh-sheng Chan
Journal:  Curr Opin Gastroenterol       Date:  2004-11       Impact factor: 3.287

9.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

10.  Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction.

Authors:  Christel Gremion; Benno Grabscheid; Benno Wölk; Darius Moradpour; Jürg Reichen; Werner Pichler; Andreas Cerny
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  7 in total

Review 1.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

Review 2.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

3.  Japanese encephalitis virus co-opts the ER-stress response protein GRP78 for viral infectivity.

Authors:  Yi-Ping Wu; Chung-Ming Chang; Chun-Yu Hung; Meng-Chieh Tsai; Scott C Schuyler; Robert Yung-Liang Wang
Journal:  Virol J       Date:  2011-03-20       Impact factor: 4.099

4.  Zebrafish as a potential model organism for drug test against hepatitis C virus.

Authors:  Cun-Bao Ding; Jing-Pu Zhang; Ye Zhao; Zong-Gen Peng; Dan-Qing Song; Jian-Dong Jiang
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

Review 5.  Unfolded protein response in hepatitis C virus infection.

Authors:  Shiu-Wan Chan
Journal:  Front Microbiol       Date:  2014-05-20       Impact factor: 5.640

Review 6.  Mouse models of liver cancer: Progress and recommendations.

Authors:  Li He; De-An Tian; Pei-Yuan Li; Xing-Xing He
Journal:  Oncotarget       Date:  2015-09-15

Review 7.  Genetically Engineered Mouse Models for Liver Cancer.

Authors:  Kyungjoo Cho; Simon Weonsang Ro; Sang Hyun Seo; Youjin Jeon; Hyuk Moon; Do Young Kim; Seung Up Kim
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.